AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Eloxx Pharmaceuticals, Inc.

$13.45 +$13.45 (+13,449,900%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$13.18
Day Range
$12.98$13.85
Year Range
$8.20$23.40
Market Cap
46.22M
AVG Volume
43.34K
Trailing/Forward PE
-8.85/-
PEG ratio
0.09
Dividend Yield
-
Next Earnings Date
2026-11-10
Primary Exchange
NASDAQUS
Net Income (USD) · A
-80M-60M-40M-20M0201620182019202020212022
ELOX Net Income (USD) by year
PeriodNet Income (USD)
2022-36.06M
2021-66.73M
2020-34.58M
2019-50.87M
2018-47.19M
2016-5.96M
Operating Income (USD) · A
-60M-40M-20M0201620182019202020212022
ELOX Operating Income (USD) by year
PeriodOperating Income (USD)
2022-34.42M
2021-43.35M
2020-29.44M
2019-50.55M
2018-45.68M
2016-2.87M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ELOX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 10 Nov 2026.

Eloxx Pharmaceuticals, Inc.
ELOX
Stockpicker

Video analysis: ELOX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ELOX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.